CReDO 2023

CReDO 2023 workshop
The Tata Memorial Centre, Mumbai and the National Cancer Grid of India conductedthe fifthsixth CReDO workshopat Lonavla, near Mumbai between 5th and 10th March 2023.


Funding agencies

St Jude Global

Larsen and Toubro India

World Health Organization South-East Asia Region (WHO SEAR)

City Cancer Challenge (C/Can)

King’s College, London

Tata Memorial Centre, Mumbai


Endorsing/supporting agencies

American Society of Clinical Oncology

Cancer Research UK

Medical Research Council - Clinical Trials Unit at University College London

Nature Reviews Clinical Oncology

Institute of Cancer Policy

The Lancet Oncology

R4HC MENA (Research for health in conflict)

 This conference was organized under the auspices of the European Organisation for Research and Treatment of Cancer (EORTC)

 Pre-workshop online learning was facilitated by Project ECHO.

Ajay Aggarwal

King’s College London

Rajendra Badwe

Tata Memorial Centre, Mumbai

Partha Basu

International Agency for Research on Cancer, Lyon

Nickhill Bhakta

St Jude Global

Christopher Booth      

Queen’s University, Kingston

Marc Buyse

International Drug Development Institute, Brussels

Carlo Caduff

King’s College London

Girish Chinnaswamy

Tata Memorial Centre, Mumbai

David Collingridge

The Lancet Oncology

Meenakshi (Mini) Devidas

St Jude Global

Caitlyn Duffy

St Jude Global

Chris Frampton

University of Otago, New Zealand

Durga Gadgil

Tata Memorial Centre, Mumbai

Dylan Graetz

St Jude Global

Allan Hackshaw

Cancer Research UK and UCL Cancer Trial Centre, London

I-Chan Huang

St Jude Global

Sally Hunsberger

National Institute of Allergy and Infectious Disease, NIH, USA

David Hunter

University of Oxford

S P Kalantri

Mahatma Gandhi Institute of Medical Sciences (MGIMS), Sevagram, Maharashtra.

Mark Krailo

University of Southern California

Ruth Langley

MRC Clinical Trials Unit at University College London

Indranil Mallick

Tata Medical Center, Kolkata

Daniel Moreira

St Jude Global

Raj Nair

Patient advocate

Sreekumaran Nair

JIPMER, Puduchery

Xavier Paoletti

University of Versailles St Quentin and at the Institut Curie, Paris 

Mahesh Parmar

MRC Clinical Trials Unit at University College London

Prachi Patil

Tata Memorial Centre, Mumbai

C S Pramesh

Tata Memorial Centre, Mumbai

Arnie Purushotham

King’s College London

Preetha Rajaraman

US Department of Health and Human Services (HHS)

A S Ramakrishnan

Cancer Institute, Adayar, Chennai, India

Priya Ranganathan

Tata Memorial Centre, Mumbai

Carlos Rodriguez-Galindo

St Jude Global           

Diana Romero

Nature Reviews Clinical Oncology

Manju Sengar

Tata Memorial Centre, Mumbai

Richard Sullivan

King’s College London

Ian Tannock

Princess Margaret Cancer Centre, Toronto

Shivakumar Thiagarajan

Tata Memorial Centre, Mumbai

Elisabete Weiderpass

International Agency for Research on Cancer, Lyon

Denis Xavier

St John’s Medical College and Research Institute, Bengaluru, India


National

1.          

Akash Pradhan

Karkinos Healthcare, India

2.          

Ameya Bindu

Tata Memorial Centre, India

3.          

Amiti Varma

Centre for Mental Health law and Policy, Pune, India

4.          

Anhad Mehra

Medica Cancer Centre, Kolkata

5.          

Anil Tibdewal

Tata Memorial Centre, India

6.          

Anuj Kumar

Tata Memorial Centre, India

7.          

Dharma Ram Poonia

AIIMS, Jodhpur, India

8.          

Gargi Das

Cancer Institute, Adayar, India

9.          

Hemavathi Baskarane

AIIMS, IRCH, New Delhi

10.       

Indhuja M.V

Cancer Institute, Adayar, India

11.       

Indraja Devidas Dev

Tata Memorial Centre, India

12.       

Jyotiman Nath

BBCI, Guwahati, India

13.       

Kantamani Teja

Tata Memorial Centre, India

14.       

Laboni Sarkar

Tata Memorial Centre, India

15.       

Latika Kansal

Tata Memorial Centre, India

16.       

Laxma Reddy Mekala

Tata Memorial Centre, India

17.       

Manisha Nandkumar Pawar

Tata Memorial Centre, India

18.       

Maqbul Alam

Tata Memorial Centre, India

19.       

Maya Prasad

Tata Memorial Centre, India

20.       

Nalla Anuraag Reddy

Kasturba Medical College, Mangalore, India

21.       

Parmod Kumar

AIIMS Rishikesh, India

22.       

Partha Pratim Medhi

AIIMS Guwahati, India

23.       

Prakash S

AIIMS Rishikesh, India

24.       

Prakruthi S. Kaushik

Kidwai Memorial Institute of Oncology, India

25.       

Prasanna Vani Vanamail

Cancer Institute, Adayar, India

26.       

Rakesh L John

Amala Institute, Kerala, India

27.       

Rakesh Mishra

Benares Hindu University, India

28.       

Reshma A

JIPMER, Puduchery, India

29.       

Sankalp Singh

Army R and R Hospital, New Delhi, India

30.       

Sharath Kumar HJ

Tata Memorial Centre, India

31.       

Shruti Kakkar

DMC Ludhiana, India

32.       

Siva Sree Kesana

Cancer Institute, Adayar, India

33.       

Srinivas Kodaganur Gopinath

Tata Memorial Centre, India

34.       

Sunaina Wadhwa

CNCI, Kolkata, India

35.       

Sushil Selvarajan

CMC Vellore, India

36.       

Venkatesh Kapu

Tata Memorial Centre, India

37.       

Vignesh Subramani

Tata Memorial Centre, India

38.       

Vikas Gupta

MGM Mumbai, India

39.       

Vineet Kumar

Tata Memorial Centre, India

40.       

Vinod Ramani

HCG Bengaluru, India

41.       

Vinotha Thomas

CMC Vellore, India

 

International

1.      

Adriana Morais

Hospital Universitário Oswaldo Cruz, Brazil

2.      

Aleksandre Iovashvili

Caucasus Medical Centre, Georgia

3.      

Anip Joshi

Bir Hospital, National Academy of Medical Sciences (NAMS), Nepal

4.      

Anna Zelwianska

Institute of Mother and Child, Poland

5.      

Astrid Riveros

Hospital del Niño, Bolivia

6.      

Eliana Lopez Baron

Hospital Pablo Tobon Uribe, Colombia

7.      

Emile Munyambaraga

University of Rwanda, Rwanda

8.      

Erika Elena Villanueva Hoyos

Solca-Quito Hospital, Ecuador

9.      

Erika Montalvo

Solca-Quito Hospital, Ecuador

10.    

Evelinda Nava

Venezuelan Institute of Social Security, Venezuela

11.    

Glaucia Regina Costa Murra

Barretos Children’s Cancer Hospital, Brazil

12.    

Hasan Hashem

King Hussein Cancer Center, Jordan

13.    

Hugo Antonio Romo Rubio

Hospital Civil de Guadalajara, Mexico

14.    

Nur Melani Sari

Universitas Padjadjaran-Dr. Hasan Sadikin Hospital, Indonesia

15.    

Pablo Miguel Gonzalez-Montalvo

Servicios De Salud De Yucatan, Mexico

16.    

PrabaniMadumarachchi

National Cancer Institute, Sri Lanka

17.    

Pradeep Siriwardena

National Cancer Institute, Sri Lanka

18.    

Rasheed Ofosu-Poku

Komfo Anokye Teaching Hospital, Ghana

19.    

Richard Nyeko

Uganda Cancer Institute, Uganda

20.    

Sabrina Q. Florendo (Villanueva)

Baguio General Hospital and Medical Center, Phillipines

21.    

Shushan Hovsepyan

Pediatric Cancer and Blood Disorders Center of Armenia

22.    

Sol Irupé Aponte Bonzi

Hospital de Clínicas, Paraguay

23.    

Suman Khanal

BP Koirala Memorial Cancer Hospital, Nepal

24.    

Urvashi Jain

King’s College London

 

Observers

1.    

Kiran Rajole

SMBT Hospital, Nashik, India

2.    

Lovin Wilson

SMBT Hospital, Nashik, India

3.    

Akash Pawar (Statistician)

Tata Memorial Centre, India

4.    

Mohit Pandey (Statistician)

International Institute for Population Sciences, Mumbai, India

5.    

Omkar Salvi (Statistician)

Tata Memorial Centre, India

6.    

Anil Patil (Statistician)

Tata Memorial Centre, India

7.    

Jagathnath Krishna (Statistician)

Regional Cancer Centre, Thiruvananthapuram, India

8.    

Vishal Deo (Statistician)

Indian Council of Medical Research, New Delhi, India

Feedback

“This was an absolute cracker of a week in every way possible” – Sankalp Singh

“Thank you, CReDO for giving such wonderful moments” – Jagath Nath Krishna

“This was a great opportunity for learning, networking and enjoying” – Eliana Lopez Baron

“Thank you to the CReDO team. Today I take with me a lifetime of friendships and an enlightened mind. What else can beat that in life?” – Anhad Mehra

“An enriching and lifetime experience” – Sunaina Wadhwa

“Stimulating conversations, cross-learning and so many new connections” – Amiti Verma

“Thank you for this amazing experience” – Erika Montalvo

“The whole workshop was a great learning experience for me. It was so meticulously organized. I had a fabulous time, academically and socially.” – Denis Xavier

  • 1.         

    Adriana Morais

    Thymus and activation-regulated chemokine (TARC) as diagnosis and treatment response marker for paediatric Hodgkin lymphoma: A multi-institutional study on the north east coast

    2.         

    Akash Pradhan

    Training a cadre of Informal Healthcare Providers at the block-level in West Bengal for early identification of common cancers and reduction in delayed diagnosis: A Randomised Controlled Trial.

    3.         

    Aleksandre Iovashvili

    Collaborative Care model for patient well-being

    4.         

    Ameya Bindu

    Study of long-term clinical outcomes and quality of life in patients with Orbitomaxillary defect (Brown Type III) reconstruction using free tissue transfer

    5.         

    Amiti Varma

    Exploring associations between drivers and risk factors of suicide among cancer patients

    6.         

    Anhad Mehra

    Resection in locally advanced oral cancers post NACT – based on pre NACT versus post NACT extent: a Randomised Controlled Trial

    7.         

    Anil Tibdewal

    PROton based Dose Escalation to Gross Disease versus Photon based Standard Dose in Locally Advanced Non-Small Cell Lung Cancer – A Phase II/III Randomized Controlled Trial (PRODEL)

    8.         

    Anip Joshi

    To find out the outcome of breast cancer patients in Bir Hospital, National Academy of Medical Sciences

    9.         

    Anna Zelwianska

    Cabozantinib in newly diagnosed patients with high risk soft tissue sarcoma.

    10.      

    Anuj Kumar

    Optimal Chemoradiation for Unresectable Head and Neck Cancers

    11.      

    Astrid Riveros

    Determination of serum asparaginase levels in pediatric patients being treated for ALL and LY with the POLA guide, in the Hospital Del Niño Dr. Ovidio Aliaga, from 2023 to 2028.

    12.      

    Dharma Ram Poonia

    Upfront Surgery vs Induction Chemotherapy followed by surgery in Oral Cancers with advanced nodal disease (SurVIc Trial): A Randomised Controlled Trial

    13.      

    Eliana Lopez Baron

    Vitamin D levels in children with cancer admitted to a pediatric intensive care in a middle income country and its relation to outcomes

    14.      

    Emile Munyambaraga

    Evaluation of a cancer patient navigation program in Rwanda: a mixed method.

    15.      

    Erika Elena Villanueva Hoyos

    Identify opportunities for improvement in the diagnosis and treatment of patients with CNS tumors

    16.      

    Erika Montalvo

    Improved outcomes after successful implementation of a pediatric early warning system (PEWS) in an emergency area in a resource-limited pediatric oncology hospital

    17.      

    Evelinda Nava Prada

    Nimotuzumab in the treatment of pediatric patients with malignant brain tumors, Two (2) years’ experience in the Republic Bolivarian from Venezuela February 2016 –February 2018.

    18.      

    Gargi Das

    Nasogastric tube feeding versus oral feeding for treatment of moderate to severe acute undernutrition in children with cancer: a randomized, open-label, parallel-group, phase III trial.

    19.      

    Glaucia Regina Costa Murra

    Acute Leukemias - Amarte Alliance epidemiologic study

    20.      

    Hasan Hashem

    Using Machine Learning Algorithms to Delineate Intestinal Microbiome Diversity for the prediction of Acute Graft-versus-Host-Disease (GvHD) in Allogeneic Hematopoietic Cell Transplantation (HCT).

    21.      

    Hemavathi Baskarane

    Liquid biopsy-based risk stratification and intensification of treatment in EGFR mutant advanced NSCLC

    22.      

    Hugo Antonio Romo Rubio

    Minimal residual disease-based guided therapy for pediatric acute lymphoblastic leukemia in México through prospective evaluation and precision risk classification

    23.      

    Indhuja M.V

    A multicenter phase 3 open label randomised control non inferiority trial comparing low dose Dasatinib and standard of Care in newly diagnosed chronic phase chronic myeloid leukemia patients

    24.      

    Indraja Devidas Dev

    Phase I/II trial of 177 Lu-DOTA-RGD radioligand therapy in progressive/ recurrent high-grade gliomas.

    25.      

    Jyotiman Nath

    Temozolomide added to preoperative chemoradiotherapy in MGMT hypermethylated locally advanced rectal cancer patients:
    Hospital based prospective study.

    26.      

    Kantamani Teja

    Impact of early palliative care in operable locally advanced oral cavity SCC - a RCT

    27.      

    Laboni Sarkar

    Outcomes of telemedicine in comparison with outpatient visits in patients with hematological malignancies: A randomized controlled study

    28.      

    Latika Kansal

    Utilizing Sentinel Lymph Node Biopsy to Identify the Lymphatic Drainage Pattern in Clinically Node Negative Recurrent Oral Cavity Squamous Cell Carcinoma.

    29.      

    Laxma Reddy Mekala

    A phase II study to determine the efficacy of Posaconazole as antifungal prophylaxis in adolescent and adults with acute lymphoblastic leukemia.

    30.      

    Manisha Nandkumar Pawar

    Effect of virtual reality headset device on pain, fear and anxiety in Pediatric Cancer Patients during Lumbar Punctures (LP) at tertiary care center in Mumbai.

    31.      

    Maqbul Alam

    Primary (immediate) versus secondary (delayed) dental implants in the prosthetic rehabilitation of head and neck cancer (HNC) patients undergoing free-fibula flap - A prospective randomized controlled study

    32.      

    Maya Prasad

    The impact of micronutrient supplementation in children with cancer: A randomized open-labelled controlled study

    33.      

    Nalla Anuraag Reddy

    Back to School project: Factors affecting school re-integration of Indian children with Acute Lymphoblastic Leukaemia (ALL) on maintenance chemotherapy.

    34.      

    Nur Melani Sari

    Evaluation of Rituximab Efficacy and Safety in High Risks B-NL and B-AL in Modified LMB Protocol in Low-Middle-Income Country

    35.      

    Pablo Miguel Gonzalez- Montalvo

    MAS-ALL-23, a Minimal Residual Disease based, Risk-Adapted treatment for Acute Lymphoblastic Leukemia in Mexico

    36.      

    Parmod Kumar

    Gemcitabine and Carboplatin Versus Gemcitabine and Paclitaxel Chemotherapy in Cisplatin Ineligible Advanced Stage Urothelial Cancers- A Prospective Randomized Control Study.

    37.      

    Partha Pratim Medhi

    Intensity modulated radiotherapy to reduced target volume after neoadjuvant chemotherapy in locoregionally advanced nasopharyngeal carcinoma and its impact on survival, toxicities and quality of life: A prospective randomized clinical trial.

    38.      

    PrabaniMadumarachchi

    Identifying the best indicator of nutritional status at baseline that can predict outcomes of childhood Acute Lymphoblastic Leukaemia (ALL) in Sri Lanka

    39.      

    Pradeep Siriwardena

    Developing a risk prediction model to guide treatment in low resource setting for treating adults with Acute Myeloblastic Leukaemia(AML)

    40.      

    Prakash S

    Factors causing delay in diagnosis of lung cancer assessed at a tertiary care centre in North India

    41.      

    Prakruthi S. Kaushik

    Graded prednisolone therapy in Pediatric Acute lymphoblastic Leukemia/Lymphoma – An open label randomised control trial

    42.      

    Prasanna Vani Vanamail

    A multicentric, randomized controlled trial to determine the effect of Surgical Plethysmographic Index guided anaesthesia management in reducing the post-operative complication in major oral surgeries for cancer.

    43.      

    Rakesh L John

    A comparative study between Buprenorphine sublingual and Tramadol oral tablets in the management of moderate pain in cancer patients.

    44.      

    Rakesh Mishra

    Radiomics in adult and pediatric neurooncology: Correlation study with extent or resection, survival and Prognosis

    45.      

    Rasheed Ofosu-Poku

    Development and Trial of an Integrated Model for Oncology and Palliative care for Management of Breast and Cervical Cancer in the Kumasi City (IMOP-Trial)

    46.      

    Reshma A

    A Multi-Stage Mixed-Method Study to understand factors associated with abandonment of treatment among adult patients with cancer and to develop a tool for its prediction.

    47.      

    Richard Nyeko

    Reduced-intensity induction regimen and maintenance therapy for acute myeloid leukemia in a resource-limited context: a randomized clinical trial

    48.      

    Sabrina Q. Florendo (Villanueva)

    Effect of Web-Based Short Message Service (SMS) Reminders on Scheduled Appointments of Pediatric Cancer patients in a Tertiary Hospital: A Randomized Controlled Trial

    49.      

    Sankalp Singh

    A study of the benefit of combination of palliative radiotherapy with immunotherapy in the treatment of metastatic lung cancer

    50.      

    Sharath Kumar Hj

    A two-stage basket study to evaluate the prophylactic efficacy of Sodium Copper Chlorophyllin for the prevention of acute radiation injury at various anatomical sites in cancer patients

    51.      

    Shruti Kakkar

    Prognostic implication of measurable residual disease in children with acute myeloid leukemia.

    52.      

    Shushan Hovsepyan

    A randomized, placebo-controlled study investigating the neuroprotective effect of oral vitamin B complex in combination with glutamine and separately in children, adolescents, and young adults with cancer receiving vincristine

    53.      

    Siva Sree Kesana

    Role of mirtazapine in cancer-associated anorexia cachexia and quality of life in patients with advanced lung cancer - A randomized, double-blind, placebo-controlled phase II trial.

    54.      

    Sol Irupé Aponte Bonzi

    Development of a follow-up plan for the cancer survivor patient. Clinical and paraclinical aspects.

    55.      

    Srinivas Kodaganur Gopinath

    High Intensity Interval Training (HIIT) for pre-habilitation in patients undergoing major lung resections: A Randomised controlled
    trial.

    56.      

    Suman Khanal

    Billroth-II with Braun anastomosis vs Roux en Y gastrojejunostomy in D2 distal gastrectomy for operable gastric cancer

    57.      

    Sunaina Wadhwa

    Title: Lymphadenectomy in Early-stage epithelial Ovarian Cancer, Is it needed? A Prospective Randomized Trial for the assessment of benefits of role of lymphadenectomy and its effect on survival outcomes.

    58.      

    Sushil Selvarajan

    Safety and feasibility of cellular therapy with CD45RA depletion for the prophylaxis of viral infections in Haplo-identical stem cell transplantation

    59.      

    Urvashi Jain

    A non-inferiority based randomised controlled trial comparing immediate pre-pectoral implant-based breast reconstruction
    (IBBR) with and without biological Extra-Cellular Matrix (ECM)

    60.      

    Venkatesh Kapu

    A phase III Randomized study to compare two different dosing strategies of Rasburicase in adult acute leukemia and high-grade lymphomas with established tumor lysis syndrome.

    61.      

    Vignesh Subramani

    Efficacy of baseline rectal swab culture-directed antimicrobial therapy for management of febrile neutropenia in children with hematological malignancies –A randomised phase III study.

    62.      

    Vikas Gupta

    Cancer screening study, to screen for breast, cervix and head/neck cancers at the community level

    63.      

    Vineet Kumar

    Comparison of clinical, cosmetic and quality of life outcomes of oncoplastic breast surgery excised and reconstructed by same surgeons versus different surgeons

    64.      

    Vinod Ramani

    Associated risk factors and the interaction of obesity, alcohol consumption and physical inactivity among colorectal cancer
    cases: a case control study from a South Indian cancer hospital.

    65.      

    Vinotha Thomas

    An evaluation of the diagnostic role of cell free HPV DNA during surveillance following treatment of cervical cancer in detection of recurrence: an observational study.